SCHEMBL18813076

SCHEMBL18813076

Cc1ccc2cc(-n3nnc4cnc(NC5CCCC5)nc43)ccc2n1.O=C(O)NCCO

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ MAPK6 Q16659 10/20 0.49
▸ GSK3A P49840 1/20 0.48
▸ GSK3B P49841 1/20 0.48
▸ EIF2AK4 Q9P2K8 6/20 0.40
▸ MAPK8 P45983 1/20 0.38
▸ MAPK9 P45984 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ CDK4 P11802 2/20 0.37
▸ CCND1 P24385 2/20 0.37
▸ CCND2 P30279 1/20 0.37
▸ CCND3 P30281 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18813096 0.91 MAPK6 (0.49) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL18813417 0.91 GSK3A (0.45) MAPK6GSK3AGSK3BEIF2AK4MAPK8
Carbamic Acid SCHEMBL18813041 0.90 MAPK6 (0.56) MAPK6GSK3AGSK3BEIF2AK4MAPK8
SCHEMBL18813078 0.89 GSK3A (0.44) MAPK6GSK3AGSK3BEIF2AK4
Carbamic Acid SCHEMBL18813046 0.89 MAPK6 (0.55) MAPK6GSK3AGSK3BEIF2AK4MAPK8
SCHEMBL18830045 0.89 MAPK6 (0.54) MAPK6GSK3AGSK3BEIF2AK4MAPK8
SCHEMBL18830178 0.88 MAPK6 (0.53) MAPK6GSK3AGSK3BEIF2AK4MAPK8
SCHEMBL16022103 0.87 EIF2AK4 (0.51) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL18813039 0.87 MAPK6 (0.46) MAPK6GSK3AGSK3BEIF2AK4MAPK8
SCHEMBL18813081 0.84 GSK3A (0.55) MAPK6GSK3AGSK3BEIF2AK4MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP claimed
Send feedback